Programmed death‐ligand 1 expression on CD22‐specific chimeric antigen receptor‐modified T cells weakens antitumor potential

The molecules of programmed cell death protein‐1 (PD‐1) and ligand‐1 (PD‐L1) become new therapeutic targets for cancer therapy. Although tumor‐expressed PD‐L1 molecule is frequently dispensable for checkpoint blockade in some cancer patients, recent studies suggest that T cell‐expressed PD‐L1 molecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jie, Zhang, Fengjuan, Yu, Jian, Zhao, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149589/
https://www.ncbi.nlm.nih.gov/pubmed/35665369
http://dx.doi.org/10.1002/mco2.140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149589/
https://www.ncbi.nlm.nih.gov/pubmed/35665369
http://dx.doi.org/10.1002/mco2.140

Ejemplares similares